Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Rohto discovers alpha-MSH inhibitors for the treatment of dermatological disorders

Sep. 8, 2009

Peplin to be acquired by Leo Pharma for USD 287.5 million in cash

Sep. 4, 2009

Clinuvel receives European approval to initiate phase III trial of afamelanotide in EPP

Sep. 1, 2009

Morria obtains clearance to conduct phase II MRX-6 study for contact dermatitis

Aug. 27, 2009

Wisconsin Alumni Research Foundation describes VDR ligands for skin conditions

Aug. 26, 2009

Peplin completes enrollment in final phase III ingenol mebutate trial in AK

Aug. 20, 2009

Almirall develops antedrug PDE4 inhibitors for psoriasis

Aug. 19, 2009

Mount Sinai added as site for phase II PH-10 trial for psoriasis

Aug. 19, 2009

Kuros reports data with KUR-212 in burn victims requiring mesh grafting

Aug. 14, 2009

Novel vitamin D3 derivatives reported for the treatment of psoriasis

Aug. 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...